Dror Ben-Asher co-founded RedHill Biopharma in 2009 and serves as the Company's CEO and Chairman. Dror has extensive managerial and transactional expertise, he was previously with ProSeed Capital, a European corporate finance boutique. Dror is a graduate of the University of Oxford (M.Jur.) and completed LL.M. studies at Harvard University, where he was a Fulbright Scholar focusing on the pharmaceutical industry and markets, an Olin Fellow for Law, Economics and Business, and an Economics Teaching Fellow at Harvard’s Economics Department. Dror received an LL.B. with distinction (First Class Honors) from the University of Leicester.